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ABSTRAK  
Objektif: Untuk menentukan corak morfologi  bronchiectasis dan korelasi tahap  
keterukan  penyakit berdasarkan penilaian Modified Reiff CT di kalangan pesakit 
bronchiectasis  dewasa dengan hasil klinikal. 
Metodologi: Pesakit dengan penemuan positif dalam HRCT thoraks  dikenal pasti  
 
daripada sistem PACS, Jabatan Radiologi, HUSM. Kriteria subjek adalah pesakit berusia  
 
18 tahun ke atas dan disahkan  kes bronchiectasis oleh HRCT thoraks  scan. Setiap imej  
 
HRCT thoraks  dikaji semula dan skor di berikan berdasarkan kepada sistem scor Reiff.  
 
Rekod perubatan pesakit dikaji semula dan bilangan tanda-tanda dan bilangan  
 
kemasukan ke hospital yang berkaitan dengan masalah pernafasan telah dikira. 
 
Keputusan: Jumlah pesakit adalah 90 orang (n=90) dengan usia purata 57.97 tahun 
 
 (45.6% lelaki, 54.4% wanita). Jenis bronchiectasis adalah  tiub  40%, varises 16.7%,  
 
sista di 12.2% dan jenis campuran 31.1%. Penilaian keparahan penyakit;  bilangan  
 
tanda-tanda menunjukkan hubungan yang lemah dan positif dengan skor Reiff  
 
diubahsuai, p-nilai 0.014. Bilangan hospitalisasi tidak menunjukkan statistik yang  
 
signifikan dengan p-nilai 0.189. 
 
Kesimpulan: Dalam kajian ini, perubahan morfologi bronchiectasis pada HRCT thorax 
 
menggunakan Modified Reiff skor mungkin menjadi prediktor untuk bilangan keterukan  
 
tetapi bukan mampu meramal  bilangan kemasukan ke hospital. 
 
 
Kata kunci: Bronchiectasis, thorax HRCT, Reiff Score Modified, exacerbation 
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ABSTRACT 
Objective: To determine the morphologic patterns of bronchiectasis and the correlation 
of disease severity based on Modified Reiff CT scoring among adult bronchiectasis 
patients with clinical outcomes. 
Methodology: Patients with positive HRCT thorax finding were traced retrospectively 
from the PACS system, Department of Radiology, HUSM.  The inclusion criteria are 
patient aged 18 years old and above and confirmed cases of bronchiectasis by HRCT 
thorax scan. Each HRCT thorax image reviewed and scored using modified Reiff. 
Patient medical records reviewed and number of exacerbation and number of 
hospitalization related to the respiratory problem were calculated. 
Results:  Total of patients are 90 (n=90) ,  with mean age of 57.97 years (45.6% male, 
54.4% female). Types of bronchiectasis were tubular in 40%, varicose in 16.7%, cystic 
in 12.2% and mix types 31.1%.  Disease severity assessment; number of exacerbation 
showed weak and positive relationship with modified Reiff score, p-value of 0.014.  
Number of hospitalization show no statistical significant with p-value of 0.189. 
Conclusions: In this study, morphological changes of bronchiectasis on HRCT thorax  
using modified Reiff may become predictor for the number of exacerbation but not a  
predictor for the number of hospitalization. 
 
Keywords: Bronchiectasis, HRCT thorax, Modified Reiff Score, exacerbation. 
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CHAPTER 1: INTRODUCTION 
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1.1 INTRODUCTION. 
Bronchiectasis is a chronic lung illness occurs due to irreversible dilatation of 
bronchial tree from destruction of the elastic and muscular components of their walls, 
usually secondary to recurrent or severe infections. Abnormal shape of bronchi and 
bronchiole cause reduction in internal pressure and this impairs clearance of mucoid and 
mucopurulent secretions. This condition usually occur secondary to other illness and 
there is a broad range of pathological processes that needs to be identified,  including 
primary disorders of bronchial structure, disease of mucus clearance, infectious causes 
and inflammatory disorders, Dähnert (2011). However, in majority of cases no cause 
could be found and half of the identified causes are due to post infectious. Common 
symptoms of this disease include chronic cough, mucopurulent sputum production, 
haemoptysis, dyspnea and tiredness. 
  
Bronchiectasis is under diagnosed and for this reason the exact prevalence of 
bronchiectasis is unknown. However, it is reported that incidence has decreased in 
developed countries with declining incidence of pulmonary tuberculosis, advancement 
of immunization and effective antibiotic treatment. According to the World Health 
Organization (WHO) in Global Burden of Disease Study 2015, lower respiratory 
infections remained the most deadly communicable disease, causing 3.2 million deaths 
worldwide and this give them at third rank of top ten causes of death.  In Malaysia, 
common causes of bronchiectasis are chronic obstructive pulmonary disease (COPD) 
and post infection especially secondary to pulmonary tuberculosis. Chronic obstructive 
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pulmonary disease also claimed 3.2 million lives in 2015 worldwide.  It is estimated that 
about 500,000 Malaysians have COPD and many of them are suffering in silence, Ban et 
al. (2012).  The lack of awareness of the disease contributes to late diagnosis of COPD 
and this disorder is one of the leading disease that causing bronchiectasis. COPD is 
ranked fifth in terms of disease burden and this is reflected in hospital admission rates 
for COPD attack. 
  
When we discussed regarding bronchiectasis severity, there are two components 
that we are looking for. First were the imaging features that we can assess the severity 
based on radiological changes. There are few scoring systems were developed to study 
on this and one of the most well-known were scoring systems described by Reiff et al. 
(1995) and Bhalla et al. (1991).  But this scoring system was not correlated with the 
clinical condition of the patient.  
 
The second component is the clinical condition of the bronchiectasis patient.  
Two studies by Martinez-Garcia et al. (2013) and Chalmers et al. (2014) had looked at 
these. They had combined the pathological state and clinical assessment in assessing the 
bronchiectasis severity. However, their assessment only focused on lung function test 
and microbiological finding. For radiological assessment, they only looked at the 
number of segment involved. 
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So, both radiology scores might not be applicable at the initial stage of diagnosis 
of bronchiectasis since a lung function test is not usually performed to all of the 
bronchiectasis patients during the initial follow-up. Sputum culture is not routinely sent 
for analysis for those patients who are managed as an outpatient in our clinical setting. 
  
High-resolution computed tomography (HRCT) thorax is a noninvasive gold 
standard in diagnosing bronchiectasis. Besides confidently providing structural 
information about the diseased lung, it plays an important role in the detection, diagnosis 
and follow-up of many lung diseases. It is also very helpful in predicting prognosis of 
the disease. This can be done by studying the correlation between radiological 
information and clinical assessment from multiple aspects.  
  
Therefore, the purpose of this study was to evaluate the morphologic changes in 
bronchiectasis lung in correlation with patient clinical condition among study population 
in Hospital Universiti Sains Malaysia, Kubang Kerian. Therefore, it is hoped that HRTC 
thorax will not only have diagnostic value but at the same time provide predictive value 
of disease progression to the clinician in order to initiate appropriate management for the 
patient. 
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The incidence of bronchiectasis is generally not well documented and is 
underestimated in the developed and developing countries. However, the prevalence is 
likely to be relatively high as bronchiectasis is a chronic condition, and the case 
ascertainment is increasing with the wider availability of computed tomography (CT) 
scanning.  A study in United Kingdom, Quint et al. (2012) has looked at database for a  
period of 7 years from 2004 until 2011.  They found that overall incidence increased 
overtime; 2004 incidence 18/100,000 years at risk and in 2011 the incidence was 
32/100,000 person years at risk. The prevalence also increased in trend, was higher in 
older age groups and was higher in women than in men. Another study by the same 
author Quint et al. (2016)  also looked at the incidence, prevalence, and mortality of 
bronchiectasis among the United Kingdom population. They focused on the database 
from 1st January 2004 until 31st December 2013. Most of their bronchiectasis patients 
were diagnosed at a secondary care setting and HRCT thorax was performed. In this 
study, the increase in trend of the incidence and prevalence as well as mortality among 
bronchiectasis patients was almost similar to the initial study. 
 
In Malaysia, specific incidence and prevalence of bronchiectasis were not well 
studied and documented. However, based on the one of the major causes of 
bronchiectasis which is chronic obstructive pulmonary disease (COPD), the prevalence 
and burden of COPD are expected to constantly increase in the coming decades due to 
continued exposure to its risk factors like cigarette smoking, changing in age and time of 
death. This directly indicates that morbidity and mortality related to this disease will 
continue to rise.  In United States, morbidity caused by COPD is 4%, making COPD the 
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fourth leading cause of death, exceeded only by heart attacks, cancer and stroke. So 
internationally, there is variation in death rates possibly reflecting smoking behavior, 
type and processing of tobacco, pollution, climate, respiratory management and genetic 
factors (Hurd, 2000). Establishing the healthcare burden is essential for allocation of 
healthcare resources and improving patient care.  
 
There are several features of bronchiectasis on plain radiograph which are tram-
track opacities, cystic changes with or without air-fluid levels, increased linear marking, 
crowding of bronchovascular marking and sometimes pulmonary vasculature appears ill-
defined (Gudbjerg, 1955). A study by  Van Der Bruggen-Bogaarts et al. (1996) 
prospectively they compared chest radiograph finding with HRCT thorax on 84 patients. 
They found that a significant linear relationship between the severity of bronchiectasis at 
HRCT and abnormalities as seen on the chest radiograph (r=0.62, p=0.001). They also 
found that chest radiograph showed high sensitivity of 87.8% with a rather low 
specificity, 74%. This was comparable with a study by Cooke et al. (1987). In their 
study of 27 patients, three radiologists were asked to assess the presence or absence of 
bronchiectasis. They found a sensitivity of the chest radiograph compared with 
bronchography of only 37% with a specificity of 95%.  Even though chest x-rays are 
usually abnormal, but are inadequate in the diagnosis or quantification of bronchiectasis 
(Collins and Stern, 2008). 
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 Naidich et al. (1982) has described types and CT signs of bronchiectasis based 
on HRCT thorax in 6 patients. These include signet rings and tramline for 
cylindrical/tubular type, presence of string of pearls for varicose type and clusters of 
rounded cyst and distended bronchi and some with air-fluid levels within for cystic type. 
Distended bronchi must be distinguished from emphysematous blebs, which generally 
have no definable wall thickness and no accompanying vessels. It was concluded that 
CT should have a role in establishing the presence and anatomic extent of 
bronchiectasis. Other non-specific feature that can be found associated with this 
condition is mucoid impaction or so called “finger in glove”. However this sign was also 
seen in other various conditions of obstructive or non-obstructive causes as stated in the 
recent review by Martinez et al. (2008). 
  
There are well described three morphological types of bronchiectasis; tubular, 
varicose and cystic types (Weissleder et al., 2011) and (Naidich et al., 2007). Several 
articles also described in detail the morphology of bronchiectasis appearance on HRCT 
and how to differentiate these condition from other lung pathology (McGuinness et al. 
(1993), Cartier et al. (1999) and  Cantin et al. (2009)).  
 
Technological advancement in CT and rapid development of therapeutic options 
in bronchiectasis has allowed CT scan to be used as the monitoring tool. Multiple CT 
scoring were developed and established  in providing an approach to qualifying disease 
and enabling structure-function relationships (Aziz et al., 2007). CT findings provide the 
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morphologic information about the disease and a scoring system was developed to offer 
a reliable way to monitor disease status and progression of disease radiologically. Thus, 
CT scan may provide a reasonable tool to assess treatment interventions.   
 
One of the most well-known first scoring systems was Bhalla scoring system 
(Bhalla et al., 1991).  Bhalla scoring system has nine components to assess and the score 
was given based on the severity of peribronchial thickening, the extent of bronchiectasis, 
the extent of mucous plugs, the presence of abscesses or sacculations, bronchial 
generations affected, the number of bullae, the extent of emphysema and presence of 
collapse or consolidation. A study had found that Bhalla scoring system was more 
sensitive than pulmonary function test in detecting initial morphological changes 
(Cademartiri et al., 2008). Bhalla scoring system is currently used for evaluation of 
cystic fibrosis bronchiectasis. However, there are many more CT scoring systems have 
been developed mainly modified, for cystic fibrosis type of bronchiectasis.  A study by 
Jong and Tiddens (2007) showed that the inter-observer agreement for five established 
scoring systems- Castile, Bhalla, Hebich, Santamaria and Brody score were good with 
intraclass coefficients ranging from 0.74 to 0.97. To date, it has not been determined 
which scoring systems is the most superior in detecting clinical relevant changes. 
 
For assessment of non-cystic fibrosis bronchiectasis, Modified Reiff score was 
chosen because of its simplicity and more practical to daily clinical work. This scoring 
system assesses the number of lobes involved with lingula segment considered to be a 
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separate lobe and the severity of bronchial dilatation in comparison to the adjacent 
vessel (0=no bronchiectasis; 1= 1-2 times; 2= 2-3 times; 3= >three times), in other word 
tubular type=1 point, varicose type=2 point and cystic type=3 point. The maximum 
score is 18 and the minimum score is 1 (Reiff et al., 1995). Ninety three consecutive 
HRCT thorax were assessed by chest physician and radiologist in which two scoring 
systems (Modified Reiff and Bhalla Score) were correlated with sputum microbiology 
and FEV1% as outcome  (Mandal et al., 2013). They found that, Modified Reiff score 
correlated well with the more complicated Bhalla score with p-value of <0.001. In 
conclusion, Modified Reiff score was a simplified score and will be easier for clinicians 
to use in clinical practice. 
 
An international derivation and validation study of the bronchiectasis severity 
index by Chalmers et al. (2014) has identified independent predictors of hospitalization 
and mortality in bronchiectasis patient. Predictors for future hospitalization were prior 
hospital admission, FEV1 <30% predicted, Pseudomonas aeruginosa  colonization, 
colonization with other pathogenic organisms and three or more lung lobes involved on 
HRCT thorax. Whereas, independent predictors of mortality were older age, low FEV1, 
lower body mass index, prior hospitalization and three or more exacerbation in the year 
before their study.  An outcome of this study, bronchiectasis severity was classified as 
mild, moderate and severe. Each has its own morbidity and mortality prediction. In mild 
bronchiectasis, 1 year outcomes: 0 - 2.8 % mortality rate, 0 - 3.4 % hospitalisation rate; 
4 year outcomes: 0 - 5.3 % mortality rate, 0 - 9.2 % hospitalisation rate. In moderate 
bronchiectasis, 1 year outcomes: 0.8 - 4.8 % mortality rate, 1.0 - 7.2 % hospitalisation 
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rate; 4 year outcomes: 4 % - 11.3 % mortality rate, 9.9 - 19.4 % hospitalisation rate.  In 
severe bronchiectasis 1 year outcomes: 7.6 % - 10.5 % mortality rate, 16.7 - 52.6 % 
hospitalisation rate; 4 year outcomes: 9.9 - 29.2 % mortality, 41.2 - 80.4 % 
hospitalisation rate. 
 
A study by Martinez-Garcia et al. (2013) had come out with a score as 
assessment of severity tool for non-cystic fibrosis bronchiectasis. FACED score consists 
of five variables; FEV1, age, chronic colonization by Pseudomonas aeruginosa, number 
of lobe involved and dyspnea. These two scores, Bronchiectasis Severity Index and 
FACED score later on were compared by Minov et al. (2015) and they found similar 
results regarding the assessment of severity of bronchiectasis for both scores.  
 
A study by Cademartiri et al. (2008) has showed that CT score significantly 
changed between the scans obtained in a mean interval of 36.5 months, whereas 
functional pulmonary test result did not, suggesting that CT is more sensitive than 
function tests for detecting small changes.  This finding able to highlight that CT scoring 
system is a good predictive tool in managing bronchiectasis patient. 
 
Therefore, the purpose of this study was to evaluate the morphologic changes in 
bronchiectasis lung correlating with patient clinical condition.  Number of exacerbation 
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and number of hospitalization were justified as indicators of patient’s clinical condition 
among study population in Hospital Universiti Sains Malaysia, Kubang Kerian. 
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CHAPTER 3: OBJECTIVE 
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3.1 OBJECTIVES 
 
3.1.1 GENERAL OBJECTIVE: 
To determine the morphological patterns of bronchiectasis and the correlation of disease 
severity based on Modified Reiff CT scoring among adult bronchiectasis patients with 
clinical outcomes. 
 
 
3.1.2 SPECIFIC OBJECTIVES: 
1. To determine the morphologic patterns of bronchiectasis among those diagnosed with 
bronchiectasis. 
2. To determine the disease severity based on Modified Reiff CT scoring. 
3. To correlate the Modified Reiff CT scoring with number of exacerbations and number 
of hospitalization as clinical outcomes. 
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CHAPTER 4: METHODOLOGY 
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4.1  STUDY DESIGN: 
 This is a retrospective cohort study which was conducted at Hospital 
Universiti Sains Malaysia. Data collection started from May 2016 until March 
2018 
 
4.2 POPULATION AND SAMPLE 
 
4.2.1  Reference population 
            Patients who have diagnose with bronchiectasis. 
4.2.2  Source population 
All adult subjects from outpatient and inpatient who had HRCT thorax 
performed at Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan from 
1
st
 January 2010 until 31
st
 December 2016. 
4.2.3 Sampling method 
Convenience sampling was performed to all HRCT thorax cases which 
were performed from 1
st
 January 2010 until 31
st
 December 2016. A total of 
approximately 200 cases of HRCT thorax performed within this 6 years of 
duration. 
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4.2.4 INCLUSION CRITERIA: 
1.  Age, 18 years old and above. 
2. Positive finding of bronchiectasis by HRCT thorax. 
 
4.2.5 EXCLUSION CRITERIA: 
1. Underlying cystic fibrosis. 
2. Active mycobacterial disease (including active nontuberous mycobacteria 
(NTM)). 
3. History of previous lung resections. 
4. No other major parenchymal lung disease e.g lung malignancy, lung 
metastasis. 
5. Suboptimal image due to cardiorespiratory motion artifact. 
6. Missing images from PACS. 
7. Non-traceable medical record. 
 
4.3 SAMPLE SIZE CALCULATION:  
Sample size is calculated using sample size calculator (Version 2.0). Available 
from http://wnarifin.github.io, http://www.medic.usm.my/biostat/articles/118-sample-
size-calculator.html 
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For objective 1: 
The sample size calculation using single proportion.  (Chalmers et al., 2014) 
Proportion(p)=8.6% 
Precision=5.0% 
Confident level, alpha =0.05. 
Drop-out=10% 
Sample size: 121 
 
For objective 2: 
The sample size calculation using single proportion. (Quint et al., 2016) 
Proportion(p)=5% 
Precision=5.0% 
Confident level, alpha =0.05. 
Drop-out=10% 
Sample size: 73 
 
For objective 3: 
The sample size calculation using two means comparison (independent).  
SD =4.8.  (Stretton et al., 2012) 
Precision=3.48 
Power of study is 0.8,  
Confident level, alpha is 0.05 
Drop out 10% 
19 
 
Sample size=34 
 
The largest sample size is n= 121 patients (from objective 1). 
After adding 10% estimated missing data, we get; n=121 + (0.1 x 121) =133. 
Therefore, a total patient to be sampled is 133 patients. 
 
 
4.4 MATERIALS AND METHOD 
 
4.4.1 Research Tools: 
1. CT Scanner: Siemens SOMATOM sensation 64; Siemens AG, Munich, 
Germany. HRCT thorax protocol:  Patient was in supine position: Images were acquired 
during breath holding at full inspiration. Scanning anatomical coverage was from lung 
apices through the diaphragm to include both adrenal glands in craniocaudal direction. 
Non contrasted study. 
The parameters include: 100-120kVp, 100-150mAs (dependent on patient habitus); 
rotation time 0.5s, average acquisition time: 8-10 sec, detector collimation: 64 x 0.6mm, 
section thickness 1mm, pitch 0.8cm.  
Reconstruction parameters: Images were reconstructed  into a bone algorithm, 1mm in 
slice thickness, 10mm reconstruction spacing, B80f kernel and image were obtained by 
using standard lung window settings (window level,-500 HU; window width,1000-1500 
HU). 
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2. Picture Achieve and Communication System (PACS) in HUSM (PACS 
universal viewer version 5.0 SP6). PACS is a computerized system means of replacing 
the roles of conventional radiological film. Radiological images are acquired, stored, 
transmitted, and displayed digitally creating a filmless clinical environment. Once the 
image has been acquired onto PACS it cannot be lost, stolen or misfiled. It will available 
all the time for viewing anywhere in the hospital. 
 
3. Diagnostic 2 mega pixel monitors (Barco). 
This is multi-modality diagnostic display monitor by BARCO which all images from 
PACS were reviewed. There were 2 types monitor BARCO available. Barco MDNC-
3421 with resolution of 2048 x 1536 and Barco MDNG-6121 with resolution 2096 x 
2800. 
 
4.4.2 Operational Definition 
 
a) Bronchiectasis is abnormal and persistent dilatation of the smaller bronchi 
mainly the segmental or sub-segmental bronchi. At HRCT, the characteristic of 
bronchiectasis included the following findings:   
i) Bronchus visualized within 1 cm of pleural surface  
ii) Lack of tapering of bronchi”tram-track”sign   
iii) Internal bronchial diameter larger than the diameter of the accompanying 
pulmonary artery, (diameter of bronchus should measure approximately <1 times 
that adjacent pulmonary artery branch)” signet-ring”sign. 
21 
 
Three morphological patterns of bronchiectasis, adapted from (Cantin et al., 2009): 
 
Figure 1: Type 1 of bronchiectasis 
Tubular/ cylindrical bronchiectasis: bronchi have a uniform calibre, do not taper and 
have parallel walls. 
 
 
 
22 
 
 
 
Figure 2: Type 2 of bronchiectasis. 
Varicose bronchiectasis: beaded appearances where dilated bronchi have interspersed 
sites of relative narrowing. 
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Figure 3: Type 3 of bronchiectasis. 
Cystic bronchiectasis: cyst-like bronchi that extend to the pleural surface. 
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b) Modified Reiff score: Radiological severity of bronchiectasis was assessed 
using a modified Reiff score, which assesses the number of lobes involved (with the 
lingula segment considered to be a separate lobe) and the morphological changes 
(tubular=1, varicose=2, and cystic=3).  The maximum score is 18 and minimum score is 
1. Each lobe was assessed for the morphological type of bronchiectasis. When there 
were 2 types of morphology within one lobe, a higher score of morphology was taken as 
final. We just looked at the types of morphology and not the number of morphology 
within each lobe of the lung. 
 
Table 1: Modified Rieff score: 
 Right lung Left lung 
Upper lobe   
Middle/Lingular lobe   
Lower lobe   
 
Total point; 
0-4 points: Low score 
5-8 points: Intermediate score 
9 or more points: High score. 
References: Reiff et al. (1995),Chalmers et al. (2014).  
 
 
